Form 8-K - Current report:
SEC Accession No. 0001104659-25-021773
Filing Date
2025-03-07
Accepted
2025-03-07 16:45:18
Documents
13
Period of Report
2025-03-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258627d1_8k.htm   iXBRL 8-K 28070
  Complete submission text file 0001104659-25-021773.txt   199457

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20250305.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20250305_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20250305_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm258627d1_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 25720771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)